It is a chemicals and materials public limited company based in Hyderabad, Telangana, India, established in 1988.
1988 | Hyderabad, Telangana, India | ActiveVijlak Pharma Limited, a active public limited company, was established on 08 February 1988 in Hyderabad, Telangana, India. Engaging in industrial chemicals within the chemicals and materials sector, it holds CIN: U25209TG1988PLC008288. Registered under ROC Roc Hyderabad. it is unlisted. It has an authorized capital of ₹1.75 Cr and a paid-up capital of ₹1.75 Cr.
Formerly known as Vij Lak Engineers Private Limited, Vijlak Pharma Private Limited. It upholds a active non-compliant status. Its leadership includes Raghava Reddy Kunam (Managing Director), Sudhakar Reddy Chadalavada (Director), Kunam Rajani (Director). Past directors included Edukondala Reddy Avula, Chandra Reddy Mareddy, Mallikarjuna Reddy Venati. It holds ₹151.75 Cr open charges and no settled loans. Its latest AGM occurred on 25 July 2013, with the balance sheet filed on 31 March 2013. It is based at Flat No. 204, Satya Sai Residency, Dharamkaram Road, Ameerpet,, Hyderabad, Telangana, 500016.
U25209TG1988PLC008288
008288
08 February 1988
₹1.75 Cr
₹1.75 Cr
Roc Hyderabad
Unlisted
Active
Explore comprehensive insights into Vijlak Pharma Limited — covering financial performance, compliance records, Competitor, shareholding patterns, directors, key metrics, and litigation history. Unlock to see detailed insights and stay informed.
Access Report
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
| Raghava Reddy Kunam | Managing Director | 23 Feb 2009 | Current |
| Sudhakar Reddy Chadalavada | Director | 02 Mar 2009 | Current |
| Kunam Rajani | Director | 23 Feb 2009 | Current |
| Anil Reddy Kunam | Director | 02 Mar 2009 | Current |
| Name | Designation | Cessation | Status |
|---|---|---|---|
| Pramod Abcsdd | Director | 19 Mar 2012 | Past |
| Pramod Abcsdd | Director | 28 Feb 2009 | Past |
| Pramod Abcsdd | Managing Director | 28 Feb 2009 | Past |
| Pramod Abcsdd | Director | 02 Mar 2009 | Past |
Discover detailed profiles of directors and KMP - Unlock leadership insights today!
Enhance accessibility to Vijlak Pharma's financial data by unlocking access to both Standalone and Consolidated balance sheets, Profit & Loss Statements, Ratios, Related Party Transactions, and additional relevant information.
| Metrics |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue | |||||||
| Revenue from Operations | |||||||
| Total Assets | |||||||
| Profit or Loss | |||||||
| Net Worth | |||||||
| EBITDA |
Unlock access to Vijlak Pharma's control and ownership data, Corporate Shareholding Patterns, Funding (security allotment) details, Foreign Institutional Investor information, Directors and Key Management Personnel (KMP) Remuneration, Group Structure, Overseas Direct Investment and other pertinent data.
Reveal ownership structures and financial performance - Get instant access now!
₹1,517,500,000.00
₹0
| Date | Lender | Amount | Status |
|---|---|---|---|
| 08 Dec 2010 | State Bank Of India | ₹12.15 Cr | Open |
| 29 Jan 2010 | State Bank Of India | ₹131.00 Cr | Open |
| 20 Dec 1997 | State Bank Of India | ₹8.60 Cr | Open |
Explore comprehensive loan charge details -
Unlock and access historical data on people associated with Vijlak Pharma, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Gain comprehensive insights into the Deals and Valuation data of Vijlak Pharma, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Vijlak Pharma's trajectory.
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
Progress on Vijlak Pharma Limited last Annual general meeting of members was held on 25 Jul 2013 as per latest MCA records. was documented.
Progress on Vijlak Pharma Limited has filed its annual Financial statements for the year ended 31 Mar 2013 with Roc Hyderabad. was documented.
The activity A charge with State Bank Of India of Rs. 131.00 Cr registered on 29 Jan 2010 with Charge ID 10201884 was modified on 29 Feb 2012. was completed.
A charge with State Bank Of India amounted to Rs. 12.15 Cr with Charge ID 10260879 was registered on 08 Dec 2010. was recorded as a recent event.
A charge with State Bank Of India amounted to Rs. 131.00 Cr with Charge ID 10201884 was registered on 29 Jan 2010. was recorded as a recent event.
Progress on A charge with State Bank Of India of Rs. 8.60 Cr registered on 20 Dec 1997 with Charge ID 80003858 was modified on 21 Jul 2009. was documented.
The CIN of Vijlak Pharma Limited is U25209TG1988PLC008288.
Vijlak Pharma Limited is headquartered at Flat No. 204, Satya Sai Residency, Dharamkaram Road, Ameerpet,, Hyderabad, Telangana, 500016.
Vijlak Pharma Limited was incorporated on 08 February 1988.
The current directors of Vijlak Pharma Limited are
The primary industry of Vijlak Pharma Limited is Chemicals And Materials.
Vijlak Pharma Limited is unlisted.
The authorized capital of Vijlak Pharma Limited is ₹1.75 Cr, and the paid-up capital is ₹1.75 Cr.
The compliance status of Vijlak Pharma Limited is Active Non-Compliant.
Search company & director profiles for free and gain access to critical business data.
Company Details
+91-XXXXXXXXXX